Remission of bronchial asthma after viral clearance in chronic hepatitis C

被引:0
|
作者
Norihiko Yamamoto
Kazumoto Murata
Takeshi Nakano
机构
[1] Japan
[2] The First Department of Internal Medicine Mie University School of Medicine
[3] Tsu
关键词
Bronchial asthma; Chronic hepatitis C; IFN therapy;
D O I
暂无
中图分类号
R512.63 []; R562.25 [];
学科分类号
1002 ; 100201 ; 100401 ;
摘要
A 53-year-old man with a history of blood transfusion at the age of 20 was admitted to our hospital because of liver dysfunction. He had bronchial asthma when he was 18 years old, which naturally resolved within 2 years. However, his bronchial asthma recurred at the age of 45 and was treated with oral theophylline. He was diagnosed as having chronic hepatitis C based on the histological and clinical findings, and then interferon (IFN) therapy was administered. The frequency of bronchial asthma attack was gradually decreasing after IFN therapy with marked improvement of hypereosinophilia. He achieved sustained viral response (SVR) and his bronchial asthma did not worsen even after the cessation of IFN. Hepatitis C virus (HCV) infection and IFN therapy were considered in the remission of asthma in this case. HCV infection could be the cause of bronchial asthma, especially in patients with late appearance of asthma.
引用
收藏
页码:7545 / 7546
页数:2
相关论文
共 50 条
  • [21] Low viraemia at enrollment in children with chronic hepatitis C favours spontaneous viral clearance
    Chen, S. -T.
    Ni, Y. -H.
    Chen, P. -J.
    Chen, H. -L.
    Jeng, Y. -M.
    Lu, M. -Y.
    Wu, J. -F.
    Hsu, H. -Y.
    Chang, M. -H.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (11) : 796 - 801
  • [22] Distinct Patterns of the Lipid Alterations between Genotype 1 and 2 Chronic Hepatitis C Patients after Viral Clearance
    Chang, Ming-Ling
    Tsou, Yung-Kuan
    Hu, Tsung-Hui
    Lin, Cheng-Hui
    Lin, Wey-Ran
    Sung, Chang-Mu
    Chen, Tsung-Hsing
    Cheng, Mei-Ling
    Chang, Kuo-Chin
    Chiu, Cheng-Tang
    Yeh, Chau-Ting
    Pang, Jong-Hwei Su
    Shiao, Ming-Shi
    PLOS ONE, 2014, 9 (08):
  • [23] Link between plasminogen activator inhibitor-1 and cardiovascular risk in chronic hepatitis C after viral clearance
    Chang, Ming-Ling
    Lin, Yu-sheng
    Pao, Li-Heng
    Huang, Hsin-Chih
    Chiu, Cheng-Tang
    SCIENTIFIC REPORTS, 2017, 7
  • [24] Link between plasminogen activator inhibitor-1 and cardiovascular risk in chronic hepatitis C after viral clearance
    Ming-Ling Chang
    Yu-sheng Lin
    Li-Heng Pao
    Hsin-Chih Huang
    Cheng-Tang Chiu
    Scientific Reports, 7
  • [25] Spontaneous viral clearance during acute hepatitis C
    Buffet, C
    PRESSE MEDICALE, 2003, 32 (25): : 1156 - 1157
  • [26] Immune mechanisms of viral clearance and pathogenesis of hepatitis C
    Wedemeyer, H
    IMMUNOLOGICAL DISEASES OF LIVER AND GUT, 2004, 135 : 57 - 71
  • [27] Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals
    Nevola, Riccardo
    Rinaldi, Luca
    Zeni, Letizia
    Romano, Ciro
    Marrone, Aldo
    Galiero, Raffaele
    Pafundi, Pia Clara
    Acierno, Carlo
    Vetrano, Erica
    Adinolfi, Luigi Elio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (06) : 643 - 656
  • [28] Spontaneous remission of chronic hepatitis C in children
    T. Fujisawa
    H. Komatsu
    A. Inui
    Y. Miyagawa
    M. Onoue
    I. Sekine
    S. Yokota
    R. Hanada
    K. Yamamoto
    M. Inui
    European Journal of Pediatrics, 1997, 156 : 773 - 776
  • [29] Spontaneous remission of chronic hepatitis C in children
    Fujisawa, T
    Komatsu, H
    Inui, A
    Miyagawa, Y
    Onoue, M
    Sekine, I
    Yokota, S
    Hanada, R
    Yamamoto, K
    Inui, M
    EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (10) : 773 - 776
  • [30] Hypozincemia in Chronic Hepatitis C Is Improved with Viral Clearance by Direct-acting Antiviral Agents
    Shirahashi, Ryosaku
    Suda, Toshikuni
    Tamano, Masaya
    INTERNAL MEDICINE, 2021, 60 (05) : 675 - 680